FDA approves label updates for BMS’ CAR T cell therapies
Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates…
News
Viatris gains China approval for Yupelri to treat COPD
Novo Nordisk teams up with WeightWatchers in latest telehealth push
Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies
Vor Bio back from brink with autoimmune drug deal rising to $4bn
BioCity’s SC0062 gains NMPA breakthrough therapy designation
Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025
UK steps up with £1.25bn Gavi vaccine pledge as US funding disappears
